Discounted tickets are available now!
New York Professional Events List
7th Drug Formulation, Solubility & Bioavailability
Date
Link to Website
Organizer
Venue
Location
7th Drug Formulation, Solubility & Bioavailability
|
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL’s 7th Drug Formulation, Solubility & Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success. This event provides you with an unmatched focus on the latest technologies and team skills that you need to gather and interpret first-in-human results and accelerate time-to-market.
Top Five Reasons to Attend
- Breakthroughs in oral biologics delivery
- Deeper understanding of self-association to enhance formulation performance
- Strategies to design, interpret and rank the performance of the next generation of predictive models
- Skills for getting long-term stability answers in the shortest time possible
- Latest insights on 3D printing applications for enabled formulations
FULL-DAY SEMINAR ON ADVANCES IN DRUG DELIVERY: Featuring oral biologics, long-acting injectables, amorphous biologics, depot microparticles, targeted tissue delivery – and much more!
Who Should Attend
This event is designed for pharmaceutical, biotech and medical device professionals responsible for the following areas:
|
|
This event is also of interest to:
|
|
Advances in Drug Delivery Seminar
Monday, March 26, 2021
8:45AM – 9:00AM
INTRODUCTION FROM SEMINAR CHAIRPERSON
Joachim Hoechel, Head, Clinical Pharmacology, BAYER
9:00AM – 9:45AM
ALTERNATIVES TO ORAL DOSING ROUTES
Meena Venugopal, Vice President, Biopharmaceutics, ALVOGEN
9:45AM – 10:30AM
PANEL: ACHIEVE BREAKTHROUGHS IN ORAL BIOLOGICS DELIVERY
Moderator:
Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, MEDIMMUNE
11:00AM – 11:45AM
Robert Prud’homme, Professor, Chemical and Biological Engineering, PRINCETON UNIVERSITY
11:45AM – 12:30PM
MAKE ADVANCES IN LONG-ACTING INJECTABLE DELIVERY OF PEPTIDES
Liping Zhou, Head of Formulation Development, RA PHARMACEUTICALS
12:30PM – 1:15PM
Jaymin Shah, Research Fellow, Pharmaceutical Sciences, Parenteral Development Centre of Emphasis, PFIZER
2:15PM – 3:00PM
SOLUBILITY AND FORMULATION APPROACHES FOR INJECTABLE DRUGS
Neera Jain, Senior Director, CMC, SYROS PHARMACEUTICALS
3:45PM – 4:30PM
MAINTAIN NECESSARY FLEXIBILITY IN THE CLINICAL TESTING AND PRODUCTION OF SOLID DOSAGE TABLETS
Joachim Hoechel, Head, Clinical Pharmacology, BAYER
4:30PM –
Wednesday, March 28, 2021
9:00AM – 9:15AM
CHAIRPERSON’S RECAP OF DAY ONE
Keith Horspool, Vice President, Pharmaceutics, BOEHRINGER INGELHEIM
MANAGING COMMON FORMULATION SETBACKS
9:15AM – 10:00AM
SHORTEN THE BRIDGE FROM PRECLINICAL TO CLINICAL DATA GATHERING
Joachim Hoechel, Head, Clinical Pharmacology, BAYER
11:15AM – 12:00PM
COMPARE ADVANTAGES AND DISADVANTAGES OF MULTIPLE OPTIONS FOR AMORPHOUS FORMULATION DEVELOPMENT
Karthik Nagapudi, Senior Scientist, GENENTECH
12:00PM – 12:45PM
ENGINEER AMORPHOUS SOLID DISPERSIONS FOR DRUG DELIVERY
Pavithra Sundararajan, Assistant Principal Scientist, Preclinical Development, MERCK
1:45PM – 2:30PM
FOCUS ON THE PROCESS OF OPTIMIZATION WITHIN R&D
Gail Dempsey, EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH
2:30PM – 3:15PM
UPDATE YOUR PREFORMULATION SKILLS FOR CONTINUOUS MANUFACTURING
3:15PM –
Faculty
Rossitza Alargova
Director, Formulations, INFINITY PHARMACEUTICALS
Gail Dempsey
EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH
Rakesh Dixit
Vice President, R&D, Global Head, Biologics Safety, MEDIMMUNE
Emilija Fredro-Kumbaradzi
Manager, Biowaivers and Biocorrelations, APOTEX
Ruchi Gupta
Scientist, MEDIMMUNE
Joachim Hoechel
Head, Clinical Pharmacology, BAYER
Keith Horspool
Vice President, Pharmaceutics, BOEHRINGER INGELHEIM
James Huckle
Scientist, Basic Pharmaceutics, Oral Delivery Product and Process Development, AMGEN
Fady Ibrahim
Principal Scientist, Biopharmaceutics, PFIZER
Neera Jain
Senior Director, CMC, SYROS PHARMACEUTICALS
Wen Lin
Senior Investigator, NOVARTIS
Eric Munson
Professor, Pharmaceutical Technology, UNIVERSITY OF KENTUCKY
Karthik Nagapudi
Senior Scientist, GENENTECH
Robert Prud’homme
Professor, Chemical and Biological Engineering, PRINCETON UNIVERSITY
Fenghe Qiu
Senior Research Fellow, BOEHRINGER INGELHEIM
Robert Saklatvala
Director, Basic Pharmaceutical Sciences, MERCK
Manuel Sanchez-Felix
Senior Fellow, Formulations, NOVARTIS
Jaymin Shah
Research Fellow, Pharmaceutical Sciences, Parenteral Development Centre of Emphasis, PFIZER
Pavithra Sundararajan
Assistant Principal Scientist, Preclinical Development, MERCK
Meena Venugopal
Vice President, Biopharmaceutics, ALVOGEN
Dedong Wu
Senior Scientist, ASTRAZENECA
Liping Zhou
Head, Formulation Development, RA PHARMACEUTICALS
Andy Zhu
Head, Preclinical Oncology Modeling and Simulations, TAKEDA
Please contact Marilyn Turner: Phone: +1 929 900 1853 Email: marilyn.turner [a] nyeventslist.com for registrations